Ozempic Updates from 2024 December 19, 2024: Two New Studies Link Ozempic to NAION, Possibly Leading to Investigation by European Medicines Agency The findings of two medical studies conducted by the University of Southern Denmark have led the Danish Medicines Agency (DMA) to ask for an investigation into the link between Ozempic use and the rare eye condition NAION
Moreover, relaxin-treated patients showed improvement in long-term outcomes, with an estimated 87% decrease in the risk of cardiovascular death (CVD) or re-hospitalization due to HF or renal failure at day 60, as well as improved 180-day survival (Table 1)
Reimbursement for obesity-focused GLP-1 therapies remains inconsistent, particularly for oral formulations indicated for obesity management
They do not interfere with each other and may work in a complementary way to support gut health and immune function
Here's what you need to know: Insulin Resistance : GLP-1 drugs improve how the body handles insulin, reducing androgen production and improving ovulation
45 Likewise, sleep deprivation in both humans and animals lowers total glutathione and impairs antioxidant defenses in various tissues